nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—SHBG—semen—hepatitis B	0.0446	0.198	CbGeAlD
Danazol—CYP19A1—semen—hepatitis B	0.0362	0.16	CbGeAlD
Danazol—AR—semen—hepatitis B	0.032	0.142	CbGeAlD
Danazol—Laboratory test abnormal—Entecavir—hepatitis B	0.0297	0.0736	CcSEcCtD
Danazol—CCL2—blood plasma—hepatitis B	0.0279	0.124	CbGeAlD
Danazol—SHBG—blood plasma—hepatitis B	0.0163	0.0721	CbGeAlD
Danazol—Hoarseness—Lamivudine—hepatitis B	0.0131	0.0324	CcSEcCtD
Danazol—CCL2—blood—hepatitis B	0.0102	0.0453	CbGeAlD
Danazol—Gingival bleeding—Lamivudine—hepatitis B	0.0101	0.0251	CcSEcCtD
Danazol—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.0101	0.0249	CcSEcCtD
Danazol—Abdominal pain upper—Entecavir—hepatitis B	0.00823	0.0204	CcSEcCtD
Danazol—CCL2—liver—hepatitis B	0.00798	0.0354	CbGeAlD
Danazol—Throat sore—Lamivudine—hepatitis B	0.00797	0.0197	CcSEcCtD
Danazol—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0079	0.0196	CcSEcCtD
Danazol—Pancreatitis—Entecavir—hepatitis B	0.00763	0.0189	CcSEcCtD
Danazol—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00745	0.0185	CcSEcCtD
Danazol—Migraine—Telbivudine—hepatitis B	0.00728	0.018	CcSEcCtD
Danazol—Dysphonia—Lamivudine—hepatitis B	0.00698	0.0173	CcSEcCtD
Danazol—Acne—Lamivudine—hepatitis B	0.00683	0.0169	CcSEcCtD
Danazol—Abdominal pain upper—Telbivudine—hepatitis B	0.00676	0.0167	CcSEcCtD
Danazol—Cramp muscle—Telbivudine—hepatitis B	0.00666	0.0165	CcSEcCtD
Danazol—Haematuria—Entecavir—hepatitis B	0.00662	0.0164	CcSEcCtD
Danazol—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0066	0.0164	CcSEcCtD
Danazol—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00646	0.016	CcSEcCtD
Danazol—CYP3A4—blood plasma—hepatitis B	0.00639	0.0284	CbGeAlD
Danazol—Oropharyngeal pain—Lamivudine—hepatitis B	0.00632	0.0157	CcSEcCtD
Danazol—SHBG—blood—hepatitis B	0.00596	0.0264	CbGeAlD
Danazol—Alopecia—Entecavir—hepatitis B	0.00551	0.0136	CcSEcCtD
Danazol—PGR—blood—hepatitis B	0.00537	0.0238	CbGeAlD
Danazol—Back pain—Adefovir Dipivoxil—hepatitis B	0.00512	0.0127	CcSEcCtD
Danazol—Leukopenia—Entecavir—hepatitis B	0.00485	0.012	CcSEcCtD
Danazol—CYP19A1—blood—hepatitis B	0.00483	0.0214	CbGeAlD
Danazol—Sleep disorder—Lamivudine—hepatitis B	0.00482	0.0119	CcSEcCtD
Danazol—Gastroenteritis—Lamivudine—hepatitis B	0.0047	0.0117	CcSEcCtD
Danazol—SHBG—liver—hepatitis B	0.00466	0.0207	CbGeAlD
Danazol—Back pain—Telbivudine—hepatitis B	0.00431	0.0107	CcSEcCtD
Danazol—Muscle spasms—Telbivudine—hepatitis B	0.00428	0.0106	CcSEcCtD
Danazol—AR—blood—hepatitis B	0.00428	0.019	CbGeAlD
Danazol—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00423	0.0105	CcSEcCtD
Danazol—ESR1—blood—hepatitis B	0.0042	0.0186	CbGeAlD
Danazol—Migraine—Lamivudine—hepatitis B	0.0041	0.0102	CcSEcCtD
Danazol—Affect lability—Lamivudine—hepatitis B	0.0041	0.0102	CcSEcCtD
Danazol—Mood swings—Lamivudine—hepatitis B	0.00395	0.00979	CcSEcCtD
Danazol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00393	0.00975	CcSEcCtD
Danazol—Dyspepsia—Entecavir—hepatitis B	0.0039	0.00966	CcSEcCtD
Danazol—Fatigue—Entecavir—hepatitis B	0.00382	0.00946	CcSEcCtD
Danazol—Abdominal pain upper—Lamivudine—hepatitis B	0.00381	0.00944	CcSEcCtD
Danazol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0038	0.00942	CcSEcCtD
Danazol—Arthralgia—Telbivudine—hepatitis B	0.00379	0.0094	CcSEcCtD
Danazol—CYP19A1—liver—hepatitis B	0.00378	0.0168	CbGeAlD
Danazol—Cramp muscle—Lamivudine—hepatitis B	0.00375	0.0093	CcSEcCtD
Danazol—Thrombocytopenia—Telbivudine—hepatitis B	0.00356	0.00882	CcSEcCtD
Danazol—Pancreatitis—Lamivudine—hepatitis B	0.00353	0.00875	CcSEcCtD
Danazol—Body temperature increased—Entecavir—hepatitis B	0.0035	0.00867	CcSEcCtD
Danazol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00341	0.00846	CcSEcCtD
Danazol—AR—liver—hepatitis B	0.00334	0.0148	CbGeAlD
Danazol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00331	0.00821	CcSEcCtD
Danazol—ESR1—liver—hepatitis B	0.00328	0.0146	CbGeAlD
Danazol—Paraesthesia—Telbivudine—hepatitis B	0.00327	0.00809	CcSEcCtD
Danazol—Dyspepsia—Telbivudine—hepatitis B	0.0032	0.00793	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00319	0.00789	CcSEcCtD
Danazol—Asthenia—Entecavir—hepatitis B	0.00318	0.00787	CcSEcCtD
Danazol—Fatigue—Telbivudine—hepatitis B	0.00313	0.00777	CcSEcCtD
Danazol—Jaundice—Lamivudine—hepatitis B	0.00313	0.00776	CcSEcCtD
Danazol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0031	0.00768	CcSEcCtD
Danazol—Sweating—Lamivudine—hepatitis B	0.00308	0.00763	CcSEcCtD
Danazol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00306	0.00757	CcSEcCtD
Danazol—Dizziness—Entecavir—hepatitis B	0.00293	0.00725	CcSEcCtD
Danazol—Body temperature increased—Telbivudine—hepatitis B	0.00287	0.00712	CcSEcCtD
Danazol—Vomiting—Entecavir—hepatitis B	0.00281	0.00697	CcSEcCtD
Danazol—Rash—Entecavir—hepatitis B	0.00279	0.00692	CcSEcCtD
Danazol—Dermatitis—Entecavir—hepatitis B	0.00279	0.00691	CcSEcCtD
Danazol—Headache—Entecavir—hepatitis B	0.00277	0.00687	CcSEcCtD
Danazol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00275	0.0068	CcSEcCtD
Danazol—Erythema multiforme—Lamivudine—hepatitis B	0.00273	0.00676	CcSEcCtD
Danazol—Rash—Adefovir Dipivoxil—hepatitis B	0.00272	0.00675	CcSEcCtD
Danazol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00272	0.00674	CcSEcCtD
Danazol—Headache—Adefovir Dipivoxil—hepatitis B	0.00271	0.0067	CcSEcCtD
Danazol—Nausea—Entecavir—hepatitis B	0.00263	0.00652	CcSEcCtD
Danazol—Asthenia—Telbivudine—hepatitis B	0.00261	0.00646	CcSEcCtD
Danazol—Chills—Lamivudine—hepatitis B	0.00259	0.00641	CcSEcCtD
Danazol—Pruritus—Telbivudine—hepatitis B	0.00257	0.00637	CcSEcCtD
Danazol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00257	0.00636	CcSEcCtD
Danazol—Alopecia—Lamivudine—hepatitis B	0.00255	0.00632	CcSEcCtD
Danazol—Tension—Lamivudine—hepatitis B	0.00246	0.00611	CcSEcCtD
Danazol—Nervousness—Lamivudine—hepatitis B	0.00244	0.00604	CcSEcCtD
Danazol—Back pain—Lamivudine—hepatitis B	0.00243	0.00602	CcSEcCtD
Danazol—Muscle spasms—Lamivudine—hepatitis B	0.00241	0.00598	CcSEcCtD
Danazol—Dizziness—Telbivudine—hepatitis B	0.0024	0.00596	CcSEcCtD
Danazol—Tremor—Lamivudine—hepatitis B	0.00235	0.00583	CcSEcCtD
Danazol—CYP3A4—blood—hepatitis B	0.00234	0.0104	CbGeAlD
Danazol—Vomiting—Telbivudine—hepatitis B	0.00231	0.00573	CcSEcCtD
Danazol—Rash—Telbivudine—hepatitis B	0.00229	0.00568	CcSEcCtD
Danazol—Dermatitis—Telbivudine—hepatitis B	0.00229	0.00568	CcSEcCtD
Danazol—Headache—Telbivudine—hepatitis B	0.00228	0.00564	CcSEcCtD
Danazol—Vertigo—Lamivudine—hepatitis B	0.00226	0.00559	CcSEcCtD
Danazol—Syncope—Lamivudine—hepatitis B	0.00225	0.00558	CcSEcCtD
Danazol—Leukopenia—Lamivudine—hepatitis B	0.00225	0.00557	CcSEcCtD
Danazol—Loss of consciousness—Lamivudine—hepatitis B	0.00221	0.00547	CcSEcCtD
Danazol—Convulsion—Lamivudine—hepatitis B	0.00218	0.00539	CcSEcCtD
Danazol—Nausea—Telbivudine—hepatitis B	0.00216	0.00535	CcSEcCtD
Danazol—Arthralgia—Lamivudine—hepatitis B	0.00214	0.0053	CcSEcCtD
Danazol—Anxiety—Lamivudine—hepatitis B	0.00213	0.00528	CcSEcCtD
Danazol—Oedema—Lamivudine—hepatitis B	0.00205	0.00508	CcSEcCtD
Danazol—Shock—Lamivudine—hepatitis B	0.00202	0.005	CcSEcCtD
Danazol—Thrombocytopenia—Lamivudine—hepatitis B	0.00201	0.00497	CcSEcCtD
Danazol—Hyperhidrosis—Lamivudine—hepatitis B	0.00198	0.00491	CcSEcCtD
Danazol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00187	0.00463	CcSEcCtD
Danazol—Paraesthesia—Lamivudine—hepatitis B	0.00184	0.00456	CcSEcCtD
Danazol—CYP3A4—liver—hepatitis B	0.00183	0.00812	CbGeAlD
Danazol—Dyspepsia—Lamivudine—hepatitis B	0.0018	0.00447	CcSEcCtD
Danazol—Fatigue—Lamivudine—hepatitis B	0.00177	0.00438	CcSEcCtD
Danazol—Constipation—Lamivudine—hepatitis B	0.00175	0.00434	CcSEcCtD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00167	0.00452	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL2—hepatitis B	0.00166	0.0045	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—NFKB1—hepatitis B	0.00165	0.00447	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—NFKB1—hepatitis B	0.00163	0.00442	CbGpPWpGaD
Danazol—Urticaria—Lamivudine—hepatitis B	0.00163	0.00403	CcSEcCtD
Danazol—CCL2—IL23-mediated signaling events—IL6—hepatitis B	0.00162	0.00441	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—hepatitis B	0.00162	0.00441	CbGpPWpGaD
Danazol—Body temperature increased—Lamivudine—hepatitis B	0.00162	0.00401	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00161	0.00436	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—NOS2—hepatitis B	0.0016	0.00435	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CTNNB1—hepatitis B	0.0016	0.00435	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.00158	0.00428	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—PTEN—hepatitis B	0.00156	0.00424	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—hepatitis B	0.00156	0.00422	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IFNG—hepatitis B	0.00155	0.00422	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00154	0.00418	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GGT2—hepatitis B	0.0015	0.00406	CbGpPWpGaD
Danazol—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00148	0.00402	CbGpPWpGaD
Danazol—Asthenia—Lamivudine—hepatitis B	0.00147	0.00364	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—IL6—hepatitis B	0.00147	0.00398	CbGpPWpGaD
Danazol—Pruritus—Lamivudine—hepatitis B	0.00145	0.00359	CcSEcCtD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00143	0.00389	CbGpPWpGaD
Danazol—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00142	0.00386	CbGpPWpGaD
Danazol—Dizziness—Lamivudine—hepatitis B	0.00136	0.00336	CcSEcCtD
Danazol—Vomiting—Lamivudine—hepatitis B	0.0013	0.00323	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—TGFB1—hepatitis B	0.00129	0.00351	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.00129	0.00351	CbGpPWpGaD
Danazol—Rash—Lamivudine—hepatitis B	0.00129	0.0032	CcSEcCtD
Danazol—CCL2—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00129	0.0035	CbGpPWpGaD
Danazol—Dermatitis—Lamivudine—hepatitis B	0.00129	0.0032	CcSEcCtD
Danazol—Headache—Lamivudine—hepatitis B	0.00128	0.00318	CcSEcCtD
Danazol—ESR1—Estrogen signaling pathway—NFKB1—hepatitis B	0.00128	0.00348	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TNF—hepatitis B	0.00127	0.00344	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL6—hepatitis B	0.00126	0.00341	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—NFKB1—hepatitis B	0.00125	0.00339	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.00124	0.00337	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00124	0.00336	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IFNG—hepatitis B	0.00123	0.00334	CbGpPWpGaD
Danazol—Nausea—Lamivudine—hepatitis B	0.00122	0.00302	CcSEcCtD
Danazol—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.0012	0.00327	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—hepatitis B	0.00113	0.00307	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00112	0.00303	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—hepatitis B	0.00112	0.00303	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—F2—hepatitis B	0.00111	0.00301	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL2—hepatitis B	0.00109	0.00296	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—CD4—hepatitis B	0.00109	0.00296	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL10—hepatitis B	0.00107	0.00292	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—hepatitis B	0.00107	0.00289	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00103	0.0028	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—F2—hepatitis B	0.00103	0.00279	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL6—hepatitis B	0.00102	0.00277	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00102	0.00277	CbGpPWpGaD
Danazol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00102	0.00276	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—TNF—hepatitis B	0.00101	0.00273	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL6—hepatitis B	0.000975	0.00265	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—hepatitis B	0.000975	0.00265	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—hepatitis B	0.000971	0.00263	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NR0B2—hepatitis B	0.00097	0.00263	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000956	0.00259	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000947	0.00257	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—NOS2—hepatitis B	0.000945	0.00256	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000939	0.00255	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—CTNNB1—hepatitis B	0.00093	0.00252	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000918	0.00249	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—CYP2A6—hepatitis B	0.000907	0.00246	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000866	0.00235	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TGFB1—hepatitis B	0.000852	0.00231	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCL10—hepatitis B	0.000851	0.00231	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL6—hepatitis B	0.000812	0.0022	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—hepatitis B	0.000796	0.00216	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000795	0.00216	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000792	0.00215	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000786	0.00213	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—hepatitis B	0.000784	0.00213	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL10—hepatitis B	0.000778	0.00211	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000756	0.00205	CbGpPWpGaD
Danazol—Progesterone—CYP2A6—hepatitis B	0.000748	0.298	CrCbGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000743	0.00202	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000741	0.00201	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000739	0.00201	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—HSPA5—hepatitis B	0.000737	0.002	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000736	0.002	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000735	0.00199	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IFNG—hepatitis B	0.000725	0.00197	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GGT1—hepatitis B	0.000708	0.00192	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—hepatitis B	0.000701	0.0019	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00068	0.00184	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000673	0.00182	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCR5—hepatitis B	0.00066	0.00179	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SAG—hepatitis B	0.000653	0.00177	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RIT2—hepatitis B	0.000653	0.00177	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000648	0.00176	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IFNG—hepatitis B	0.000647	0.00175	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL6—hepatitis B	0.000642	0.00174	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000632	0.00172	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IFNG—hepatitis B	0.000632	0.00171	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000628	0.0017	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000615	0.00167	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000612	0.00166	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000607	0.00165	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCR5—hepatitis B	0.000603	0.00164	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.0006	0.00163	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SAG—hepatitis B	0.000598	0.00162	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RIT2—hepatitis B	0.000598	0.00162	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000581	0.00158	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000581	0.00158	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—IL2—hepatitis B	0.000575	0.00156	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000572	0.00155	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000569	0.00155	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.000567	0.00154	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—F2—hepatitis B	0.000566	0.00154	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.000566	0.00154	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL2—hepatitis B	0.000562	0.00152	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00056	0.00152	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000542	0.00147	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—NFKB1—hepatitis B	0.000538	0.00146	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—hepatitis B	0.000532	0.00144	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—PTEN—hepatitis B	0.000528	0.00143	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—F2—hepatitis B	0.000518	0.0014	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000512	0.00139	CbGpPWpGaD
Danazol—Prednisone—ALB—hepatitis B	0.000508	0.203	CrCbGaD
Danazol—Norethindrone—ALB—hepatitis B	0.000501	0.2	CrCbGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000499	0.00135	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—NFKB1—hepatitis B	0.000498	0.00135	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—CDKN1A—hepatitis B	0.000485	0.00132	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PTEN—hepatitis B	0.000484	0.00131	CbGpPWpGaD
Danazol—Methyltestosterone—ALB—hepatitis B	0.000476	0.19	CrCbGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000471	0.00128	CbGpPWpGaD
Danazol—PGR—Gene Expression—NR0B2—hepatitis B	0.000467	0.00127	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.00045	0.00122	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—hepatitis B	0.000448	0.00122	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000448	0.00121	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL10—hepatitis B	0.00044	0.00119	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000438	0.00119	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000437	0.00119	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL10—hepatitis B	0.000437	0.00118	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000432	0.00117	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL10—hepatitis B	0.000399	0.00108	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—F2—hepatitis B	0.000398	0.00108	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000395	0.00107	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.00038	0.00103	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—hepatitis B	0.000378	0.00103	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SAG—hepatitis B	0.000377	0.00102	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RIT2—hepatitis B	0.000377	0.00102	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000371	0.00101	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000371	0.00101	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000369	0.001	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000363	0.000986	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—hepatitis B	0.000361	0.000978	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.00036	0.000976	CbGpPWpGaD
Danazol—AR—Gene Expression—NR0B2—hepatitis B	0.000356	0.000966	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CCR5—hepatitis B	0.000341	0.000925	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCR5—hepatitis B	0.000339	0.000919	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—hepatitis B	0.00033	0.000896	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000327	0.000888	CbGpPWpGaD
Danazol—PGR—Gene Expression—HNF4A—hepatitis B	0.000324	0.000879	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000319	0.000866	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000318	0.000862	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000315	0.000855	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCR5—hepatitis B	0.00031	0.00084	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000308	0.000836	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000307	0.000834	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000306	0.00083	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—hepatitis B	0.000302	0.000821	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000293	0.000795	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—F2—hepatitis B	0.000293	0.000794	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—F2—hepatitis B	0.00029	0.000788	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000286	0.000775	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CDKN1A—hepatitis B	0.000285	0.000773	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000284	0.000771	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PTEN—hepatitis B	0.000284	0.000771	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00028	0.000759	CbGpPWpGaD
Danazol—Testosterone—ALB—hepatitis B	0.000276	0.11	CrCbGaD
Danazol—ESR1—Gene Expression—NR0B2—hepatitis B	0.000274	0.000744	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000272	0.000738	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKR1B1—hepatitis B	0.000267	0.000725	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—F2—hepatitis B	0.000266	0.000721	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000265	0.000719	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CTNNB1—hepatitis B	0.000259	0.000702	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL10—hepatitis B	0.000258	0.0007	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GGT2—hepatitis B	0.000256	0.000695	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000255	0.000691	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000253	0.000687	CbGpPWpGaD
Danazol—AR—Gene Expression—HNF4A—hepatitis B	0.000247	0.000669	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000243	0.000659	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000238	0.000645	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000237	0.000644	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000237	0.000642	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL10—hepatitis B	0.000236	0.00064	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000236	0.000639	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000226	0.000612	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SAG—hepatitis B	0.000221	0.0006	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RIT2—hepatitis B	0.000221	0.0006	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000218	0.000591	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00021	0.000569	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000207	0.000561	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR5—hepatitis B	0.0002	0.000543	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—hepatitis B	0.000197	0.000535	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000196	0.000532	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—hepatitis B	0.000196	0.000531	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000195	0.000529	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HNF4A—hepatitis B	0.00019	0.000516	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000183	0.000497	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR5—hepatitis B	0.000183	0.000496	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—hepatitis B	0.000179	0.000485	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—hepatitis B	0.000177	0.000482	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—F2—hepatitis B	0.000172	0.000466	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000162	0.000438	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—F2—hepatitis B	0.000157	0.000426	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2A6—hepatitis B	0.000155	0.000421	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL10—hepatitis B	0.000149	0.000404	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000145	0.000393	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GOT2—hepatitis B	0.00014	0.000381	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GGT1—hepatitis B	0.000121	0.000329	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GOT1—hepatitis B	0.000121	0.000329	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—hepatitis B	0.000116	0.000314	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—hepatitis B	0.000115	0.000313	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—hepatitis B	0.000115	0.000312	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—hepatitis B	0.000112	0.000303	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.00011	0.0003	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—hepatitis B	0.000109	0.000296	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—hepatitis B	0.000109	0.000295	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKB1—hepatitis B	0.000108	0.000294	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—hepatitis B	0.000106	0.000287	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—hepatitis B	0.000105	0.000285	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—hepatitis B	0.000102	0.000277	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—hepatitis B	9.97e-05	0.00027	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—hepatitis B	9.94e-05	0.00027	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—F2—hepatitis B	9.9e-05	0.000269	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFKB1—hepatitis B	9.9e-05	0.000269	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—hepatitis B	9.01e-05	0.000245	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL10—hepatitis B	8.73e-05	0.000237	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—hepatitis B	8.24e-05	0.000224	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1B1—hepatitis B	7.8e-05	0.000212	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT2—hepatitis B	7.47e-05	0.000203	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—hepatitis B	7.42e-05	0.000201	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—hepatitis B	6.79e-05	0.000184	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—hepatitis B	6.79e-05	0.000184	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—hepatitis B	6.77e-05	0.000184	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—hepatitis B	6.66e-05	0.000181	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—hepatitis B	6.44e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—hepatitis B	6.43e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—hepatitis B	6.29e-05	0.000171	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—hepatitis B	6.27e-05	0.00017	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKB1—hepatitis B	6.24e-05	0.000169	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—hepatitis B	6.21e-05	0.000169	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—F2—hepatitis B	5.81e-05	0.000158	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—hepatitis B	5.2e-05	0.000141	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—hepatitis B	4.92e-05	0.000133	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.53e-05	0.000123	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—hepatitis B	4.28e-05	0.000116	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT2—hepatitis B	4.1e-05	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—hepatitis B	3.92e-05	0.000106	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—hepatitis B	3.91e-05	0.000106	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—hepatitis B	3.78e-05	0.000102	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—hepatitis B	3.69e-05	0.0001	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—hepatitis B	3.68e-05	9.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKB1—hepatitis B	3.66e-05	9.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT1—hepatitis B	3.54e-05	9.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT1—hepatitis B	3.54e-05	9.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—hepatitis B	3.05e-05	8.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—hepatitis B	2.51e-05	6.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—hepatitis B	2.3e-05	6.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—hepatitis B	1.88e-05	5.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—hepatitis B	1.43e-05	3.89e-05	CbGpPWpGaD
